Ultragenyx Pharmaceutical Inc.
RAREUnited States
66 filed reports · 426 financial concepts · 1 earnings calls · 0 media appearances
Filed reports
66 reports · Mar 2015 to Jun 2026Each report counts once it has at least one extracted financial fact. Also extracted from these reports: 47 guidance figures.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Quarterly · 10-QSEC EDGAR | 35 | 4,006 | Mar 2015 to Jun 2026 |
| Current · 8-KSEC EDGAR | 20 | 47 | Dec 2019 to Jun 2026 |
| Annual · 10-KSEC EDGAR | 11 | 4,269 | Dec 2015 to Dec 2025 |
Documents
| Period | Type | Period end | Published | Facts | Source |
|---|---|---|---|---|---|
| FY2026 Q2 | 10-Q | Jun 30, 2026 | Aug 5, 2026 | 285 | Open |
| FY2026 Q2 | 8-K | Jun 30, 2026 | Aug 4, 2026 | 2 | Open |
| FY2026 Q1 | 10-Q | Mar 31, 2026 | May 6, 2026 | 166 | Open |
| FY2026 Q1 | 8-K | Mar 31, 2026 | May 5, 2026 | 2 | Open |
| FY2025 | 10-K | Dec 31, 2025 | Feb 18, 2026 | 744 | Open |
| FY2025 Q4 | 8-K | Dec 31, 2025 | Feb 12, 2026 | 2 | Open |
| FY2025 Q3 | 10-Q | Sep 30, 2025 | Nov 5, 2025 | 180 | Open |
| FY2025 Q3 | 8-K | Sep 30, 2025 | Nov 4, 2025 | 4 | Open |
| FY2025 Q2 | 10-Q | Jun 30, 2025 | Aug 6, 2025 | 124 | Open |
| FY2025 Q2 | 8-K | Jun 30, 2025 | Aug 5, 2025 | 2 | Open |
| FY2025 Q1 | 10-Q | Mar 31, 2025 | May 7, 2025 | 126 | Open |
| FY2025 Q1 | 8-K | Mar 31, 2025 | May 6, 2025 | 4 | Open |
Financial data
426 concepts · 8,322 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Financial417 concepts · 7,927 facts · Dec 2013 to Jul 2026
- Cash and cash equivalents at carrying value64 · Dec 2013 to Jun 2026
- Accretion amortization of discounts and premiums investments63 · Dec 2013 to Jun 2026
- Allocated share based compensation expense63 · Dec 2013 to Jun 2026
- Comprehensive income net of tax63 · Dec 2013 to Jun 2026
- Depreciation depletion and amortization63 · Dec 2013 to Jun 2026
- Investment income interest63 · Dec 2013 to Jun 2026
- Net income loss63 · Dec 2013 to Jun 2026
- Operating income loss63 · Dec 2013 to Jun 2026
- Other comprehensive income unrealized holding gain loss on securities arising during period net of tax63 · Dec 2013 to Jun 2026
- Payments to acquire property plant and equipment63 · Dec 2013 to Jun 2026
- Proceeds from maturities prepayments and calls of available for sale securities63 · Dec 2013 to Jun 2026
- Research and development expense63 · Dec 2013 to Jun 2026
- Other nonoperating income expense62 · Dec 2013 to Jun 2026
- Stockholders equity (US GAAP)61 · Dec 2013 to Jun 2026
- Accounts payable current59 · Dec 2014 to Jun 2026
- Accrued liabilities current59 · Dec 2014 to Jun 2026
- Accumulated other comprehensive income loss net of tax59 · Dec 2014 to Jun 2026
- Additional paid in capital59 · Dec 2014 to Jun 2026
- Assets59 · Dec 2014 to Jun 2026
- Assets current59 · Dec 2014 to Jun 2026
- Common stock shares authorized59 · Dec 2014 to Jun 2026
- Common stock shares outstanding59 · Dec 2014 to Jun 2026
- Common stock value59 · Dec 2014 to Jun 2026
- Employee related liabilities current59 · Dec 2014 to Jun 2026
Geography3 concepts · 220 facts · Mar 2015 to Jun 2026
- Revenue186 · Dec 2016 to Jun 2026
- Number of reportable segments31 · Mar 2015 to Sep 2022
- Income tax paid foreign after refund received3 · Dec 2025
Product3 concepts · 128 facts · Dec 2016 to Jun 2026
- Revenue117 · Dec 2016 to Jun 2026
- Product Revenue9 · Dec 2017 to Dec 2025
- Product Sales2 · Dec 2018 to Dec 2019
Guidance3 concepts · 47 facts · Jan 2020 to Aug 2026
- Revenue Guidance38 · Jan 2020 to Aug 2026
- Revenue Growth Guidance8 · Jan 2025 to Nov 2025
- Free Cash Flow Growth Guidance1 · May 2020
Segments
348 factsFigures broken down by business line, region, product or another axis the company reports on.
Statement geographicalsrt:StatementGeographicalAxis12 members · 208 facts
- North America36 · Dec 2018 to Jun 2026
- Europe35 · Dec 2016 to Mar 2024
- US32 · Dec 2017 to Sep 2022
- Latin America31 · Jun 2020 to Jun 2026
- Asia Pacific17 · Dec 2022 to Jun 2026
- EMEA17 · Dec 2022 to Jun 2026
- All Other16 · Jun 2018 to Dec 2021
- JP15 · Dec 2020 to Mar 2024
- US And Canada6 · Mar 2021 to Sep 2022
- BR1 · Dec 2025
- MX1 · Dec 2025
- Other1 · Dec 2025
Product or service3 members · 128 facts
- Product57 · Dec 2016 to Jun 2026
- Collaboration And License39 · Dec 2017 to Dec 2025
- Royalty32 · Mar 2020 to Jun 2026
Statement geographicalus-gaap:StatementGeographicalAxis1 member · 12 facts
- US12 · Mar 2015 to Mar 2018
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
No commentary or risk-factor text for this company.
Earnings calls
1 calls · Aug 2026Transcripts with management claims and analyst questions, one per fiscal period.
- FY2026 Q2Aug 4, 2026
Executive media
Podcasts, interviews and conference appearances by the company's executives, with their claims.
No media appearances for this company.
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 16, 2026) and refreshed every few hours.